{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:09Z","timestamp":1740147249376,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1693-0","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T11:02:24Z","timestamp":1527073344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-4256","authenticated-orcid":false,"given":"Keiki","family":"Nagaharu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Masuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryugo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiki","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"2","key":"1693_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.critrevonc.2012.07.002","volume":"85","author":"PG Gobbi","year":"2013","unstructured":"Gobbi PG, Ferreri AJM, Ponzoni M, Levis A. Hodgkin lymphoma. Crit Rev Oncol Hematol. 2013;85(2):216\u201337.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1693_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-0609.2004.00292.x","volume":"73","author":"V Franco","year":"2004","unstructured":"Franco V, Tripodo C, Rizzo A, Stella M, Florena AM. Bone marrow biopsy in Hodgkin\u2019s lymphoma. Eur J Haematol. 2004;73(3):149\u201355.","journal-title":"Eur J Haematol"},{"issue":"27","key":"1693_CR3","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1200\/JCO.2010.28.3077","volume":"28","author":"BK Shah","year":"2010","unstructured":"Shah BK, Subramaniam S, Peace D, Garcia C. HIV-associated primary bone marrow Hodgkin\u2019s lymphoma: a distinct entity? J Clin Oncol. 2010;28(27):e459\u201360.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1693_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12185-012-1127-5","volume":"96","author":"M Yotsumoto","year":"2012","unstructured":"Yotsumoto M, Hagiwara S, Ajisawa A, Tanuma J, Uehira T, Nagai H, et al. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan. Int J Hematol. 2012;96(2):247\u201353.","journal-title":"Int J Hematol"},{"issue":"11","key":"1693_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/00000478-199511000-00012","volume":"19","author":"KL Chang","year":"1995","unstructured":"Chang KL, Kamel OW, Arber DA, Horyd ID, Weiss LM. Pathologic features of nodular lymphocyte predominance Hodgkin\u2019s disease in extranodal sites. Am J Surg Pathol. 1995;19(11):1313\u201324.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1693_CR6","doi-asserted-by":"publisher","first-page":"e26302","DOI":"10.1002\/pbc.26302","volume":"64","author":"KD Westmoreland","year":"2017","unstructured":"Westmoreland KD, Stanley CC, Montgomery ND, Kaimila B, Kasonkanji E, El-Mallawany NK, et al. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017;64(5):e26302.","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"1693_CR7","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1200\/JCO.2005.01.701","volume":"23","author":"A Claviez","year":"2005","unstructured":"Claviez A, Tiemann M, Luders H, Krams M, Parwaresch R, Schellong G, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23(18):4048\u201356.","journal-title":"J Clin Oncol"},{"issue":"23","key":"1693_CR8","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","volume":"27","author":"A Diepstra","year":"2009","unstructured":"Diepstra A, van Imhoff GW, Schaapveld M, Karim-Kos H, van den Berg A, Vellenga E, et al. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin\u2019s lymphoma predicts adverse outcome in older adult patients. J Clin Oncol. 2009;27(23):3815\u201321.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1693_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3324\/haematol.2012.083048","volume":"98","author":"PL Zinzani","year":"2013","unstructured":"Zinzani PL, Viviani S, Anastasia A, Vitolo U, Luminari S, Zaja F, et al. Brentuximab vedotin in relapsed\/refractory Hodgkin\u2019s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. Haematologica. 2013;98(8):1232.","journal-title":"Haematologica"},{"issue":"4","key":"1693_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa1708984","volume":"378","author":"JM Connors","year":"2017","unstructured":"Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, et al. Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u2019s lymphoma. N Engl J Med. 2017;378(4):331\u201344.","journal-title":"N Engl J Med"},{"issue":"7","key":"1693_CR11","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"J-I Henter","year":"2002","unstructured":"Henter J-I, Samuelsson-Horne A, Aric\u00f2 M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367.","journal-title":"Blood"},{"issue":"13","key":"1693_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S1470-2045(13)70501-1","volume":"14","author":"A Younes","year":"2013","unstructured":"Younes A, Connors JM, Park SI, Fanale M, O\u2019Meara MM, Hunder NN, et al. Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin\u2019s lymphoma: a phase 1, open-label, dose-escalation study. Lancet Oncol. 2013;14(13):1348\u201356.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1693_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/590152","volume":"47","author":"F M\u00e1nard","year":"2008","unstructured":"M\u00e1nard F, Besson C, Rinc\u00e1 P, Lambotte O, Lazure T, Canioni D, et al. Hodgkin lymphoma\u2013associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis. 2008;47(4):531\u20134.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1693_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1078-0432.CCR-05-2008","volume":"12","author":"MK Gandhi","year":"2006","unstructured":"Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ, et al. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin\u2019s lymphoma. Clin Cancer Res. 2006;12(2):460\u20134.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1693_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/1097-0142(19891015)64:8<1720::AID-CNCR2820640828>3.0.CO;2-L","volume":"64","author":"LM Meadows","year":"1989","unstructured":"Meadows LM, Rosse WR, Moore JO, Crawford J, Laszlo J, Kaufman RE. Hodgkin\u2019s disease presenting as myelofibrosis. Cancer. 1989;64(8):1720\u20136.","journal-title":"Cancer"},{"issue":"1","key":"1693_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00277-002-0572-2","volume":"82","author":"H Kojima","year":"2003","unstructured":"Kojima H, Takei N, Mukai Y, Hasegawa Y, Suzukawa K, Nagata M, et al. Hemophagocytic syndrome as the primary clinical symptom of Hodgkin\u2019s disease. Ann Hematol. 2003;82(1):53\u20136.","journal-title":"Ann Hematol"},{"issue":"3","key":"1693_CR17","first-page":"Ecr04","volume":"91","author":"M Ponzoni","year":"2006","unstructured":"Ponzoni M, Ciceri F, Crocchiolo R, Famoso G, Doglioni C. Isolated bone marrow occurrence of classic Hodgkin\u2019s lymphoma in an HIV-negative patient. Haematologica. 2006;91(3):Ecr04.","journal-title":"Haematologica"},{"issue":"7","key":"1693_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3109\/10428194.2013.848982","volume":"55","author":"L Cacoub","year":"2014","unstructured":"Cacoub L, Touati S, Yver M, Frayfer J, Abarah W, Andre-Kerneis E, et al. Isolated bone marrow Hodgkin lymphoma in a human immunodeficiency virus-negative patient: a second case. Leuk Lymphoma. 2014;55(7):1675\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1693_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12185-014-1532-z","volume":"99","author":"B Dholaria","year":"2014","unstructured":"Dholaria B, Alapat D, Arnaoutakis K. Primary bone marrow Hodgkin lymphoma in an HIV-negative patient. Int J Hematol. 2014;99(4):503\u20137.","journal-title":"Int J Hematol"},{"issue":"11","key":"1693_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2169\/internalmedicine.54.3770","volume":"54","author":"Y Morita","year":"2015","unstructured":"Morita Y, Emoto M, Serizawa K, Rai S, Hirase C, Kanai Y, et al. HIV-negative primary bone marrow Hodgkin lymphoma manifesting with a high fever associated with hemophagocytosis as the initial symptom: a case report and review of the previous literature. Intern Med. 2015;54(11):1393\u20136.","journal-title":"Intern Med"},{"issue":"2","key":"1693_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12185-014-1714-8","volume":"101","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Kusumoto S, Masaki A, Ishida T, Inagaki H, Iida S, et al. CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma. Int J Hematol. 2015;101(2):109\u201311.","journal-title":"Int J Hematol"},{"issue":"12","key":"1693_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/01.MP.0000037311.56159.13","volume":"15","author":"M Ponzoni","year":"2002","unstructured":"Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol. 2002;15(12):1273\u20138.","journal-title":"Mod Pathol"},{"issue":"10","key":"1693_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/108729103322494285","volume":"17","author":"L Gerard","year":"2003","unstructured":"Gerard L, Oksenhendler E. Hodgkin\u2019s lymphoma as a cause of fever of unknown origin in HIV infection. AIDS Patient Care STDS. 2003;17(10):495\u20139.","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"1693_CR24","first-page":"604","volume":"17","author":"ME Salama","year":"2007","unstructured":"Salama ME, Perkins SL, Mariappan MR. Images in HIV\/AIDS. Primary bone marrow presentation of Epstein-Barr virus-driven HIV-associated Hodgkin lymphoma. AIDS Read. 2007;17(12):604\u20135.","journal-title":"AIDS Read"},{"issue":"1","key":"1693_CR25","first-page":"41","volume":"12","author":"M Corti","year":"2015","unstructured":"Corti M, Villafane M, Minue G, Campitelli A, Narbaitz M, Gilardi L. Clinical features of AIDS patients with Hodgkin\u2019s lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution. Cancer Biol Med. 2015;12(1):41\u20135.","journal-title":"Cancer Biol Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1693-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1693-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1693-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T09:15:53Z","timestamp":1604308553000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1693-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1693"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1693-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by the Suzuka General Hospital Ethics Committee on 30 Nov 2017 (approval number 176).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}